Hemoglobinopathies : current practices for screening, confirmation and follow-up
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

For very narrow results

When looking for a specific result

Best used for discovery & interchangable words

Recommended to be used in conjunction with other fields

Dates

to

Document Data
Library
People
Clear All
Clear All

For additional assistance using the Custom Query please check out our Help Page

i

Hemoglobinopathies : current practices for screening, confirmation and follow-up

Filetype[PDF-3.65 MB]


English

Details:

  • Corporate Authors:
  • Description:
    In 2013, the National Center on Birth Defects and Developmental Disabilities, Division of Blood Disorders (DBD), Centers for Disease Control and Prevention (CDC) in collaboration with the Association of Public Health Laboratories (APHL) Newborn Screening and Genetics in Public Health Program convened an APHL Hemoglobinopathy Laboratory Workgroup to address issues around hemoglobinopathy laboratory testing. The workgroup objectives are as follows:

    • Discuss the issues related to building and enhancing US laboratory capacity in the areas of screening and diagnosis of hemoglobinopathies.

    • Conduct an inventory of state and regional labs that are currently performing (or have the capacity to develop) sickle cell disease laboratory testing.

    • Develop a training program for implementing laboratory technology in state public health laboratories, universities, and community centers for testing.

    • Consult with CDC and other partners to evaluate current laboratory methodologies and make recommendations for improvements.

    • Identify and document best practices that have been used in SCD public health laboratory training; identify training standards and competency outcomes.

    One of the products of the APHL Hemoglobinopathy Laboratory Workgroup is this guidance document on hemoglobinopathy laboratory testing and follow-up techniques. This document explores current screening and diagnostic methods available that are currently employed by some screening and diagnostic laboratories. It also includes an overview of laboratory structure discussing algorithms for testing, reporting and follow-up from several programs in the US. Furthermore, this document aims to improve and strengthen US and international capabilities by offering best practices thereby contributing to the goal of early detection of hemoglobin disorders.

    This publication was supported by Cooperative Agreement # U60HM000803 funded by the Centers for Disease Control and Prevention. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of CDC or the Department of Health and Human Services.

    nbs_hemoglobinopathy-testing_122015.pdf

  • Subjects:
  • Document Type:
  • Funding:
  • Pages in Document:
    54 numbered pages
  • Collection(s):
  • Main Document Checksum:
  • Download URL:
  • File Type:

Supporting Files

  • No Additional Files
More +

You May Also Like

Checkout today's featured content at stacks.cdc.gov